(DE), obtained from a non-optimized extraction condition exhibited anti-Alzheimer’s disease (AD) properties through the inhibition of a rate-limiting enzyme in amyloid peptide formation, β-secretase-1 (BACE-1). This evidence concerns the gene BACE1 and early-onset autosomal dominant Alzheimer disease.